Document Type : Research Articles
Authors
1
Department of Pathology, King Georges’ Medical University, Lucknow-226003, Uttar Pradesh, India.
2
Department of Prosthodontics, Crowns and Bridges, King Georges’ Medical University, Lucknow-226003, Uttar Pradesh, India.
3
Department of Gynaecological Oncology,, King Georges’ Medical University, Lucknow-226003, Uttar Pradesh, India.
4
Department of CFAR,, King Georges’ Medical University, Lucknow-226003, Uttar Pradesh, India.
5
Department of Biochemistry, King Georges’ Medical University, Lucknow-226003, Uttar Pradesh, India.
6
Department of Critical Care Medicine, King Georges’ Medical University, Lucknow-226003, Uttar Pradesh, India.
Abstract
Background: Cervical cancer remains a major cause of mortality in low- and middle-income settings. We assessed whether two PIK3CA single-nucleotide polymorphisms (SNPs) rs6443624 (A/C) and rs141178472 (C/T) are associated with disease risk, clinicopathological features, and survival. Materials and Methods: In a prospective case control study at a tertiary center, 154 participants were enrolled (77 cases, 77 controls). Genomic DNA was isolated from FFPE cervical tumors (QIAamp DNA FFPE Tissue Kit) and genotyped using TaqMan allelic discrimination. Clinicopathological variables (FIGO stage, histology, grade, treatment, tumor-infiltrating lymphocytes [TILs]) were abstracted from records. Genotype distributions were compared by Pearson chi-square. Associations with clinicopathological features used chi-square/Fisher’s exact as appropriate; ANOVA compared age across genotypes. Overall survival (OS) was estimated by Kaplan–Meier and compared with the log-rank test; mean OS with SE and 95% CI is reported. Results: Cases were predominantly locally advanced at presentation and squamous histology; most were moderately differentiated. rs6443624 differed significantly between cases and controls (χ²=21.1, p<0.001), with CC over-represented in cases and CA less frequent. rs141178472 showed no significant case control difference (χ²=2.9, p=0.086). For OS, rs6443624 showed a significant genotype effect (log-rank χ²=23.45, p=0.001): AA had the poorest survival, CA the longest, CC intermediate. rs141178472 was not associated with OS (χ²=1.06, p=0.588). Genotype clinicopathological correlations for stage group, grade, TILs, and treatment were non-significant or inconsistent, with some comparisons limited by small sample sizes. Conclusion: The PIK3CA rs6443624 variant appears to influence both susceptibility and prognosis in cervical cancer, highlighting its potential as a biomarker for molecular risk stratification. Validation in larger, multi-center cohorts incorporating HPV/p16 assessment and extended follow-up is warranted to confirm its clinical relevance.
Keywords
Main Subjects
)